Indaptus Therapeutics Inc...

0.50
-0.02 (-2.91%)
At close: Apr 02, 2025, 3:57 PM
0.52
4.60%
After-hours: Apr 02, 2025, 07:56 PM EDT

Indaptus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 1.28K 1.78K 1.4K 852.00 854K 859K 829K 701K 745.9K 584.82K 602.85K 555.43K 340.68K 367.33K 305.53K 302.32K
Gross Profit n/a -1.28K -1.78K -1.4K -852 -854K -859K -829K -701K -745.9K -584.82K -602.85K -555.43K -340.68K -367.33K -305.53K -302.32K
Operating Income -15.37M -16.38M -14.91M -7.73M -3.6M -34.95M -43.33M -29.44M -13.85M -7.6M -7.57M -5.17M -5.37M -7.76M -5.34M -3.93M -4.91M
Interest Income n/a n/a 588.11K 17.72K 15.11K 330K 852K 286K 176K 44.78K 172.48K 111.37K 79.87K 53.94K 43.94K 1.02K 61.69K
Pretax Income -15.02M -15.42M -14.32M -7.71M -3.58M -46.96M -43.44M -28.88M -13.36M -7.18M -5.69M -5.09M -5.18M -7.58M -5.42M -3.94M -5.36M
Net Income -15.02M -15.42M -13.73M -7.69M -3.57M -47.6M -43.54M -28.91M -13.36M -7.18M -5.69M -5.09M -5.18M -7.58M -5.42M -3.94M -5.36M
Selling & General & Admin 8.11M 8.76M 8.59M 5.21M 944.25K 7.43M 7.07M 4.32M 3.07M 2.77M 2.59M 2.41M 2.12M 2.74M 2.65M 1.78M 1.67M
Research & Development 7.25M 7.62M 6.32M 2.52M 2.66M 26.66M 35.4M 24.3M 10.07M 4.09M 4.39M 2.16M 2.69M 4.69M 2.32M 1.84M 2.94M
Other Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 15.37M 16.38M 14.91M 7.73M 3.6M 34.09M 42.47M 28.61M 13.14M 6.85M 6.98M 4.56M 4.81M 7.42M 4.97M 3.62M 4.61M
Interest Expense n/a n/a 588.11K n/a n/a 15K 23K 17K 16K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a 100.74K n/a n/a n/a 7.43M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 16.38M 14.91M 7.73M 3.6M 34.95M 43.33M 29.44M 13.85M 7.6M 7.57M 5.17M 5.37M 7.76M 5.34M 3.93M 4.91M
Income Tax n/a n/a -588.11K -17.72K -15.11K 638K 103K 29K n/a -4 n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic) 9.36M 8.4M 8.26M 4.09M 486.17K 422.2K 389.91K 220.75K 143.1K 97.39K 3.02M 2.68M 2.42M 2.14M 1.71M 1.11M 716.52K
Shares Outstanding (Diluted) 9.36M 8.4M 8.26M 4.09M 486.17K 422.2K 389.91K 220.75K 143.1K 97.39K 3.02M 2.68M 2.42M 2.14M 1.71M 1.11M 716.52K
EPS (Basic) -1.61 -1.84 -1.66 -1.88 -7.34 -112.74 -111.67 -130.96 -93.38 -73.7 -1.89 -1.9 -2.14 -3.55 -3.17 -3.54 -7.48
EPS (Diluted) -1.61 -1.84 -1.66 -1.88 -7.34 -112.74 -111.67 -130.96 -93.38 -73.7 -1.89 -1.9 -2.14 -3.55 -3.17 -3.54 -7.48
EBITDA -15.37M -16.38M -14.91M -7.73M -3.6M -46.09M -42.56M -28.61M -13.14M -6.43M -5.11M -4.49M -4.63M -7.24M -5.06M -3.64M -5.06M
EBIT n/a -16.38M -14.91M -7.73M -3.6M -46.95M -43.42M -28.86M -13.35M -7.18M -5.69M -5.09M -5.18M -7.58M -5.42M -3.94M -5.36M
Depreciation & Amortization n/a 1.28K 1.78K 1.4K 852.00 854K 859K 829K 701K 745.9K 584.82K 602.85K 555.43K 340.68K 367.33K 305.53K 302.32K